Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Get trade alerts by text
We text you when insiders, Congress or big funds make new trades. Free.
Piper Sandler Reiterates Overweight Rating on AGNC Investment Corp.
Piper Sandler reaffirms its Overweight rating on AGNC Investment Corp. with a new target price of $10.
B of A Securities Upgrades BorgWarner Inc. to Buy
B of A Securities has upgraded BorgWarner's rating to Buy and raised its price target significantly.
RBC Capital Reiterates Outperform Rating on Ally Financial Inc.
RBC Capital maintains its Outperform rating and sets a price target of $50 for Ally Financial.
JP Morgan Reiterates Overweight Rating on Ally Financial Inc.
JP Morgan maintains its Overweight rating for Ally Financial, setting a price target of $43.
Morgan Stanley Downgrades Ally Financial to Equal-Weight
Morgan Stanley has downgraded Ally Financial, adjusting its price target to $43.00 on October 12, 2026.
Morgan Stanley Upgrades Manhattan Associates to Overweight
Morgan Stanley raises its rating on Manhattan Associates, boosting the price target significantly.
Stifel Reiterates Buy Rating on Manhattan Associates, Raises Target to $250
Stifel maintains its Buy rating on Manhattan Associates and raises the price target to $250.
Wells Fargo Reiterates Overweight Rating on Figma, Inc.
Wells Fargo keeps its Overweight rating on Figma with a price target of $30.
RBC Capital Maintains Outperform Rating on Toll Brothers, Inc.
Toll Brothers, Inc. sees its price target shifted as RBC Capital reaffirms its positive outlook.
Citigroup Maintains Buy Rating on Toll Brothers, Inc.
Citigroup reaffirms a Buy rating for Toll Brothers, adjusting the price target to $168 from $179.
StoneX Reiterates Buy Rating for Toll Brothers, Inc.
StoneX has reaffirmed a Buy rating on Toll Brothers with a price target of $165.
Citigroup Reiterates Buy Rating on Hasbro, Inc.
Citigroup has reaffirmed its Buy rating on Hasbro, raising the price target to $117.
Barclays Reiterates Overweight Rating on BioMarin Pharmaceutical Inc.
Barclays has reiterated its Overweight rating on BioMarin with a new price target of $114.0.
RBC Capital Reiterates Outperform Rating on Graco Inc.
RBC Capital has reaffirmed its Outperform rating for Graco Inc. with a price target of $95.00.
Oppenheimer Reiterates Outperform Rating on Lennox International Inc.
Oppenheimer has reiterated its Outperform rating on Lennox International with a price target of $548.
Goldman Sachs Downgrades Lennox International to Neutral
Goldman Sachs has lowered its rating on Lennox International, adjusting the price target significantly.
Morgan Stanley Maintains Underweight Rating on Lennox International
Morgan Stanley has reiterated its Underweight rating on Lennox International, lowering the price target to $350.
Barclays Reiterates Overweight Rating on Nextpower Inc.
Barclays has reiterated its Overweight rating on Nextpower with a target of $146.00.
Susquehanna Reiterates Positive Rating on Nextpower Inc.
Susquehanna has reiterated its Positive rating on Nextpower Inc. with a new price target of $150.
Baird Reiterates Outperform Rating on Carlisle Companies
Baird has reaffirmed its Outperform rating for Carlisle Companies with a price target of $402.
Keybanc Reiterates Overweight Rating on RPM International Inc.
Keybanc has reiterated its Overweight rating on RPM International with a new price target of $117.
TD Cowen Maintains Buy Rating on Halozyme Therapeutics
TD Cowen reiterated its Buy rating for Halozyme Therapeutics with a new price target of $130 on October 13, 2026.
Bernstein Maintains Outperform Rating on The J. M. Smucker Company
Bernstein has reiterated its Outperform rating on The J. M. Smucker Company with a new price target of $160.
Truist Securities Maintains Buy Rating on Avery Dennison
Truist Securities has reiterated its Buy rating on Avery Dennison, adjusting the price target to $208.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.